Crossmark

A potential anticancer ability of 1,2-di(quinazolin-4-yl)diselane against gastric cancer cells through ROS signaling pathway

Crossref DOI link: https://doi.org/10.1007/s00044-017-1799-8

Published Online: 2017-02-13

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Jun

Yang, Yong

Wang, Zhixiang

Wang, Zijian

Fu, Changlai

Zhu, Jianqing

Shan, Jiping

Huang, Yingjiu

Tang, Bikui https://orcid.org/0000-0003-1854-229X
Jiang, Danbin
Funding

Funding for this research was provided by:

the foundation of Key Clinical Department (Gastroenterology) of Jiangsu Province (2016) ((2016))

the YunTi Plan of Third People’s Hospital of Yancheng (2015)

the Research Fund of Bengbu Medical College (BYKF1602)

the Natural Science Foundation of Anhui Province (1708085MH192)

the Natural Science Foundation of Anhui Province (1408085MH164)
License Information

License valid from 2017-02-13